HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayoshi Arai Selected Research

dictyoceratin-C

12/2015Structure-Activity Relationship and in Vivo Anti-Tumor Evaluations of Dictyoceratin-A and -C, Hypoxia-Selective Growth Inhibitors from Marine Sponge.
3/2015Enantioselective synthesis of dictyoceratin-A (smenospondiol) and -C, hypoxia-selective growth inhibitors from marine sponge.
7/2014Marine spongian sesquiterpene phenols, dictyoceratin-C and smenospondiol, display hypoxia-selective growth inhibition against cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayoshi Arai Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 05/2004
7Hypoxia (Hypoxemia)
03/2019 - 11/2010
6Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 01/2017
6Starvation
06/2021 - 01/2016
2Sarcoma (Soft Tissue Sarcoma)
12/2015 - 11/2010
2Prostatic Neoplasms (Prostate Cancer)
07/2014 - 11/2010
1Inflammation (Inflammations)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2016
1Osteosarcoma (Osteogenic Sarcoma)
08/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2009
1Neuroblastoma
06/2009
1Aspiration Pneumonia
03/2007

Drug/Important Bio-Agent (IBA)

10Growth InhibitorsIBA
01/2020 - 04/2014
8Glucose (Dextrose)FDA LinkGeneric
06/2021 - 01/2016
4Biological ProductsIBA
04/2022 - 06/2014
4smenospondiolIBA
03/2019 - 07/2014
3Pharmaceutical PreparationsIBA
11/2020 - 01/2016
3furospinosulin-1IBA
01/2016 - 11/2010
3dictyoceratin-CIBA
12/2015 - 07/2014
2epidithiodiketopiperazineIBA
06/2021 - 01/2020
2PhenolsIBA
03/2019 - 07/2014
2SesquiterpenesIBA
03/2019 - 07/2014
2EstersIBA
12/2015 - 07/2014
2Indicators and Reagents (Reagents)IBA
10/2004 - 05/2004
13- hydroxy- 4- prenyl- 5- methoxystilbene- 2- carboxylic acidIBA
04/2022
1Cytotoxins (Cytolysins)IBA
04/2022
1NLR ProteinsIBA
01/2022
1InflammasomesIBA
01/2022
1Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
01/2022
1oridoninIBA
01/2022
1asteltoxinIBA
01/2022
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2022
1LuciferasesIBA
01/2022
1secalonic acidIBA
03/2020
1xanthoneIBA
03/2020
1aspergillazine AIBA
01/2020
1trichodermamide AIBA
01/2020
1Carbolines (Beta-Carbolines)IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1Endoplasmic Reticulum Chaperone BiPIBA
10/2018
1PolyketidesIBA
01/2017
1Halogenated Diphenyl EthersIBA
01/2017
1lens epithelium-derived growth factorIBA
01/2016
1N-methylniphatyne AIBA
01/2016
1AlkaloidsIBA
01/2016
1AmidesIBA
12/2015
1Hydroxyl RadicalIBA
12/2015
1Alkenes (Olefins)IBA
12/2015
1xylarianaphthol-1IBA
08/2014
1Phenol (Carbolic Acid)FDA Link
07/2014
1ligudentatolIBA
06/2014
1Alkynes (Acetylenes)IBA
04/2014
1tenuifolin diterpeneIBA
01/2011
1PD 128042IBA
07/2009
1AcetylcholinesteraseIBA
06/2009
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2004
1boromycinIBA
10/2004
1simaomicin alphaIBA
05/2004

Therapy/Procedure

3Therapeutics
01/2022 - 12/2020
2Oral Administration
04/2014 - 11/2010
1Total Parenteral Nutrition
03/2007